OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
EXEP56

Exel Industries SA

Agricultural ChemicalsVerified

Exel Industries has a debt-to-equity ratio of 0.3, indicating a relatively conservative capital structure with a strong equity base. The company's current ratio of 1.84 suggests it has sufficient short-term assets to cover its short-term liabilities, supporting a medium liquidity risk profile. However, the company's net cash position is negative after subtracting total debt, which could pose a challenge in maintaining liquidity under stress scenarios. In terms of profitability, Exel Industries reports a return on equity (ROE) of 3.49% and a return on assets (ROA) of 1.93%. These figures are below the industry median for Agricultural Chemicals, suggesting that the company is underperforming its peers in terms of capital efficiency and asset utilization. The operating margin, calculated as operating income divided by revenue, is 3.8%, which is also below the industry median, indicating that the company is not generating as much operating profit per euro of revenue as its competitors. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the company's exposure to regional economic downturns and regulatory changes. The absence of segment or geographic breakdown in the financial data limits the ability to assess the company's risk profile in detail. Looking at the growth trajectory, Exel Industries has not provided specific revenue growth projections for the current or next fiscal year. The company's free cash flow of 14.4 million euros is modest, and its capital expenditure of -24.9 million euros suggests that the company is not investing heavily in new projects or capacity expansion. This could indicate a conservative approach to growth or a focus on maintaining existing operations rather than expanding. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could affect its ability to meet short-term obligations without additional financing. However, the dilution risk is low, as the number of shares outstanding has not changed between basic and diluted shares, indicating no imminent threat of equity dilution. There are no recent events or filings mentioned in the provided data that would significantly impact the company's operations or financial position. The absence of recent transcripts or filings suggests that the company has not disclosed any material changes or developments in the near term.

30-day price · EXEP-2.80 (-8.8%)
Low$27.80High$33.30Close$29.00As of27 May, 00:00 UTC
Profile
CompanyExel Industries SA
TickerEXEP.PA
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. Exel Industries SA is a chemical company that produces and sells agricultural chemicals, primarily generating revenue through the sale of its chemical products to the agricultural sector.

Classification. Exel Industries is classified under the Basic Materials economic sector, within the Chemicals business sector and the Agricultural Chemicals industry, with a classification confidence of 0.92.

Exel Industries has a debt-to-equity ratio of 0.3, indicating a relatively conservative capital structure with a strong equity base. The company's current ratio of 1.84 suggests it has sufficient short-term assets to cover its short-term liabilities, supporting a medium liquidity risk profile. However, the company's net cash position is negative after subtracting total debt, which could pose a challenge in maintaining liquidity under stress scenarios. In terms of profitability, Exel Industries reports a return on equity (ROE) of 3.49% and a return on assets (ROA) of 1.93%. These figures are below the industry median for Agricultural Chemicals, suggesting that the company is underperforming its peers in terms of capital efficiency and asset utilization. The operating margin, calculated as operating income divided by revenue, is 3.8%, which is also below the industry median, indicating that the company is not generating as much operating profit per euro of revenue as its competitors. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the company's exposure to regional economic downturns and regulatory changes. The absence of segment or geographic breakdown in the financial data limits the ability to assess the company's risk profile in detail. Looking at the growth trajectory, Exel Industries has not provided specific revenue growth projections for the current or next fiscal year. The company's free cash flow of 14.4 million euros is modest, and its capital expenditure of -24.9 million euros suggests that the company is not investing heavily in new projects or capacity expansion. This could indicate a conservative approach to growth or a focus on maintaining existing operations rather than expanding. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could affect its ability to meet short-term obligations without additional financing. However, the dilution risk is low, as the number of shares outstanding has not changed between basic and diluted shares, indicating no imminent threat of equity dilution. There are no recent events or filings mentioned in the provided data that would significantly impact the company's operations or financial position. The absence of recent transcripts or filings suggests that the company has not disclosed any material changes or developments in the near term.
Key takeaways
  • Exel Industries has a conservative capital structure with a debt-to-equity ratio of 0.3, but its net cash position is negative after subtracting total debt.
  • The company's ROE and ROA are below the industry median, indicating underperformance in capital efficiency and asset utilization.
  • Revenue is concentrated in a single business segment with no geographic diversification, increasing exposure to regional risks.
  • Free cash flow is modest, and capital expenditure is negative, suggesting a conservative approach to growth.
  • The company has a medium liquidity risk and a low dilution risk, with no recent events affecting its operations.
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyEUR
Revenue$983.0M
Gross profit$475.5M
Operating income$37.2M
Net income$16.2M
R&D
SG&A
D&A
SBC
Operating cash flow$70.8M
CapEx-$24.9M
Free cash flow$14.4M
Total assets$840.4M
Total liabilities$374.5M
Total equity$465.9M
Cash & equivalents
Long-term debt$140.3M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$465.9M
Net cash-$140.3M
Current ratio1.8
Debt/Equity0.3
ROA1.9%
ROE3.5%
Cash conversion4.4%
CapEx/Revenue-2.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricEXEPActivity
Op margin3.8%5.5% medp25 -0.0% · p75 10.8%below median
Net margin1.7%4.1% medp25 0.1% · p75 8.8%below median
Gross margin48.4%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-2.5%-6.2% medp25 -13.4% · p75 -2.6%top quartile
Debt / equity30.0%37.1% medp25 10.3% · p75 82.0%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-19 09:50 UTC#75e71840
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 22:06 UTCJob: c15489f5